Sign In
Buy PGEN
$3.81
-0.0500 (-1.30%)
At Close: Jun 03, 2026
Precigen to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Monday, 19'th Dec 2022
GERMANTOWN, Md. , Dec. 19, 2022 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives o
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
04:58pm, Friday, 18'th Nov 2022 Benzinga
Upgrades
According to Summit Insights Group, the prior rating for Applied Materials Inc (NASDAQ:AMAT) was changed from Hold to Buy. For the fourth quarter, Applied Materials had an EPS of $2.03, comp
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
10:10am, Friday, 11'th Nov 2022 Benzinga
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions relat
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
11:35pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Precigen, Inc. (PGEN) delivered earnings and revenue surprises of -140% and 67.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Precigen, Inc. (PGEN) Q3 2022 Earnings Call Transcript
10:59pm, Wednesday, 09'th Nov 2022
Precigen, Inc. (NASDAQ:PGEN ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Steve Harasym - Vice President, Investor Relations Helen Sabzevari - President & Chief E
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
08:19pm, Wednesday, 09'th Nov 2022
Precigen, Inc. (PGEN) delivered earnings and revenue surprises of -140% and 67.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
09:28am, Monday, 10'th Oct 2022 Benzinga
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Inventiva S.A. (NASDAQ:
Penny Stocks To Buy Now: 3 To Watch Under $3
03:47pm, Thursday, 22'nd Sep 2022 PennyStocks
Penny stocks to buy for under $3
The post Penny Stocks To Buy Now: 3 To Watch Under $3 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stocks To Buy Now: 3 To Watch Under $3
11:47am, Thursday, 22'nd Sep 2022
Penny stocks to buy for under $3 The post Penny Stocks To Buy Now: 3 To Watch Under $3 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
08:04am, Thursday, 22'nd Sep 2022 Benzinga
Gainers
Stabilis Solutions, Inc. (NASDAQ: SLNG) shares climbed 71.3% to close at $8.84 after the company announced it has received authorization from the U.S. Department of Energy to export domestic
Circling Back On Precigen
05:24pm, Tuesday, 23'rd Aug 2022
Today, we circle back on Precigen, a biotech firm that was once part of Intrexon. Precigen is advancing several drug candidates in its pipeline and recently agreed to a divesture than significantly bo
Roblox's Stock Gets A Price Target Cut By This Analyst; Also Check Out Some Other Major PT Changes
12:22pm, Tuesday, 09'th Aug 2022 Benzinga
Truist Securities boosted the price target on Roblox Corporation (NYSE: RBLX) from $29 to $45. However, Truist Securities analyst Matthew Thornton maintained the stock with a Hold. Roblox shares fell
Precigen, Inc. (PGEN) Reports Q2 Loss, Lags Revenue Estimates
10:55pm, Monday, 08'th Aug 2022 Zacks Investment Research
Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 18.75% and 83.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Precigen, Inc. (PGEN) CEO Helen Sabzevari on Q2 2022 Results - Earnings Call Transcript
08:21pm, Monday, 08'th Aug 2022
Precigen, Inc. (NASDAQ:PGEN ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Steven Harasym - Vice President and Head of Investor Relations Helen Sabzevari - President
Precigen, Inc. (PGEN) Reports Q2 Loss, Lags Revenue Estimates
08:20pm, Monday, 08'th Aug 2022
Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 18.75% and 83.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
